Advanced search
Publication Cover
Cancer Investigation Volume 20, 2002 - Issue 5-6
Submit an article Journal homepage
11
Views
0
CrossRef citations to date
0
Altmetric
Original

Salvage Therapy for Platinum-Refractory Urothelial Cancer: Designing New Clinical Trials

Daniel P. Petrylak Columbia College of Physicians and Surgeons, Director, Geninoturinary Oncology Program, New York, New York, U.S.A.
, M.D.
Pages 855-856 | Published online: 17 Jul 2002

REFERENCES

  • Saxman S.B., Propert K.J., Einhorn L.H., et al. Long-Term Follow-Up of a Phase III Intergroup Study of Cisplatin Alone or in Combination with Methotrexate, Vinblastine, and Doxorubicin in Patients with Metastatic Urothelial Carcinoma: A Cooperative Group Study. J. Clin. Oncol. 1997; 15(7)2564–2569
  • Gebbia V., Testa A., Borsellino N. Single Agent 2′2′-Difluorodeoxycytidine in the Treatment of Metastatic Urothelial Carcinoma: A Phase II Study. Clin. Ther. 1999; 150(1)11–15
  • Witte R.S., Elson P., Bono B., Knop R., Richardson R., Dreicer R., Loeher P.J. Eastern Cooperative Oncology Group Phase II Trial of Ifosfamide in the Treatment of Previously Treated Advanced Urothelial Carcinoma. J. Clin. Oncol. 1997; 14: 489–493
  • Seidman A.D., Scher H.I., Heinemann M.H., Bajorin D.F., Sternberg C.N., Dershaw D.D., Silverberg M., Bosl G.J. Continuous Infusion Gallium Nitrate for Patients with Advanced Refractory Urothelial Tract Tumors. Cancer 1991; 68: 2561–2565
  • Roth B.J., Dreicer R., Einhorn L.H., et al. Significant Activity of Paclitaxel in Advanced Transitional-Cell Carcinoma of the Urothelium: A Phase II Trial of the Eastern Cooperative Oncology Group. J. Clin. Oncol. 1994; 12(11)2264–2270
  • de Wit R., Kruit W.H., Stoter G., de Boer M., Kerger J. Verweij JDocetaxel (Taxotere): An Active Agent in Metastatic Urothelial Cancer; Results of a Phase II Study in Non-Chemotherapy-Pretreated Patients. Br. J. Cancer 1998; 78(10)1342–1345
  • Broome, C.M.; Hussain, M.; Gutheil, J.; et al., Phase II Trial of Weekly Paclitaxel in Patients with Previously Treated Advanced Urothelial Cancer, Proc. Am. Soc. Clin. Oncol., Abstract 1381.
  • McCaffrey J.A., Hilton S., Mazumdar M., et al. Phase II Trial of Docetaxel in Patients with Advanced or Metastatic Transitional-Cell Carcinoma. J. Clin. Oncol. 1997; 15(5)1853–1857
  • Krege S., Rembrink V., Borgermann C., Otto T., Rubben H. Docetaxel and Ifosfamide as Second Line Treatment for Patients with Advanced or Metastatic Urothelial Cancer After Failure of Platinum Chemotherapy: A Phase 2 Study. J. Urol. 2001; 165(1)67–71
  • Bue P., Wester K., Sjostrom A., et al. Expression of Epidermal Growth Factor Receptor in Urinary Bladder Cancer Metastases. Int. J. Cancer 1998; 76(2)189–193

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.